27435325
2016 Nov
Background and aims:We evaluated the impact of primary variceal bleeding prophylaxis on long-term outcomes of patients newly diagnosed with hepatocellular carcinoma (HCC).Methods:A retrospective cohort of 898 patients newly diagnosed with HCC without a history of variceal bleeding [age 57.4 Â± 10.4, males 718 (80.0 %)] were analyzed for new onset variceal bleeding during follow-up.Results:Variceal bleeding occurred in 72 patients (8.0 %) during follow-up. The presence of portal vein thrombosis [hazard ratio (HR) 3.90; 95 % confidence interval (CI) 2.09-7.30; p Conclusion:Variceal bleeding was independent risk factor for survival of newly diagnosed HCC patients. Screening and providing primary prophylaxis for indicated patients should be considered for patients with HCC.
Bleeding; Hepatocellular carcinoma; Prevention; Survival; Varix.
